Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mercedes Robledo

Showing results (111-120 of 215) with videos related to

Pageof 22
Sort By:
The Lancet. Oncology|October 22, 2011
Single nucleotide polymorphism associations with response and toxic effects in patients with advanced renal-cell carcinoma treated with first-line sunitinib: a multicentre, observational, prospective studyJesus Garcia-Donas, Emilio Esteban, Luis Javier Leandro-García, et al.
Endocrine-Related Cancer|February 16, 2022
Head/neck paragangliomas: focus on tumor location, mutational status and plasma methoxytyramineSusan Richter, Bei Qiu, Mirthe Ghering, et al.
Endocrine-Related Cancer|June 20, 2013
Influence of RET mutations on the expression of tyrosine kinases in medullary thyroid carcinomaCristina Rodríguez-Antona, Iván Muñoz-Repeto, Lucia Inglada-Pérez, et al.
International Journal of Cancer|June 1, 2023
Deubiquitinase USP9X loss sensitizes renal cancer cells to mTOR inhibitionJuan M Roldán-Romero, Carlos Valdivia, Maria Santos, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 22, 2012
Regulatory polymorphisms in β-tubulin IIa are associated with paclitaxel-induced peripheral neuropathyLuis J Leandro-García, Susanna Leskelä, Carlos Jara, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|February 28, 2015
MicroRNA deep-sequencing reveals master regulators of follicular and papillary thyroid tumorsVeronika Mancikova, Esmeralda Castelblanco, Elena Pineiro-Yanez, et al.
Cancers|November 13, 2020
Novel <i>DNMT3A</i> Germline Variant in a Patient with Multiple Paragangliomas and Papillary Thyroid CarcinomaSara Mellid, Javier Coloma, Bruna Calsina, et al.
The Journal of Clinical Endocrinology and Metabolism|October 3, 2022
Recurrent Disease in Patients With Sporadic Pheochromocytoma and ParagangliomaMinghao Li, Tamara Prodanov, Leah Meuter, et al.
Clinical Chemistry and Laboratory Medicine|October 1, 2020
Plasma metanephrines and prospective prediction of tumor location, size and mutation type in patients with pheochromocytoma and paragangliomaGraeme Eisenhofer, Timo Deutschbein, Georgiana Constantinescu, et al.
Journal of Hypertension|May 16, 2020
Genetics, diagnosis, management and future directions of research of phaeochromocytoma and paraganglioma: a position statement and consensus of the Working Group on Endocrine Hypertension of the European Society of HypertensionJacques W M Lenders, Michiel N Kerstens, Laurence Amar, et al.
Pageof 22

Showing results (111-120 of 215) with videos related to

Sort By:
Pageof 22
The Lancet. Oncology|October 22, 2011
Single nucleotide polymorphism associations with response and toxic effects in patients with advanced renal-cell carcinoma treated with first-line sunitinib: a multicentre, observational, prospective studyJesus Garcia-Donas, Emilio Esteban, Luis Javier Leandro-García, et al.
Endocrine-Related Cancer|February 16, 2022
Head/neck paragangliomas: focus on tumor location, mutational status and plasma methoxytyramineSusan Richter, Bei Qiu, Mirthe Ghering, et al.
Endocrine-Related Cancer|June 20, 2013
Influence of RET mutations on the expression of tyrosine kinases in medullary thyroid carcinomaCristina Rodríguez-Antona, Iván Muñoz-Repeto, Lucia Inglada-Pérez, et al.
International Journal of Cancer|June 1, 2023
Deubiquitinase USP9X loss sensitizes renal cancer cells to mTOR inhibitionJuan M Roldán-Romero, Carlos Valdivia, Maria Santos, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 22, 2012
Regulatory polymorphisms in β-tubulin IIa are associated with paclitaxel-induced peripheral neuropathyLuis J Leandro-García, Susanna Leskelä, Carlos Jara, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|February 28, 2015
MicroRNA deep-sequencing reveals master regulators of follicular and papillary thyroid tumorsVeronika Mancikova, Esmeralda Castelblanco, Elena Pineiro-Yanez, et al.
Cancers|November 13, 2020
Novel <i>DNMT3A</i> Germline Variant in a Patient with Multiple Paragangliomas and Papillary Thyroid CarcinomaSara Mellid, Javier Coloma, Bruna Calsina, et al.
The Journal of Clinical Endocrinology and Metabolism|October 3, 2022
Recurrent Disease in Patients With Sporadic Pheochromocytoma and ParagangliomaMinghao Li, Tamara Prodanov, Leah Meuter, et al.
Clinical Chemistry and Laboratory Medicine|October 1, 2020
Plasma metanephrines and prospective prediction of tumor location, size and mutation type in patients with pheochromocytoma and paragangliomaGraeme Eisenhofer, Timo Deutschbein, Georgiana Constantinescu, et al.
Journal of Hypertension|May 16, 2020
Genetics, diagnosis, management and future directions of research of phaeochromocytoma and paraganglioma: a position statement and consensus of the Working Group on Endocrine Hypertension of the European Society of HypertensionJacques W M Lenders, Michiel N Kerstens, Laurence Amar, et al.
Pageof 22